389
Views
21
CrossRef citations to date
0
Altmetric
Drug Evaluations

Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene

, MD PhD & , OBE PhD DSc FMedSci
Pages 657-674 | Published online: 07 Feb 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (20)

Ramin Riahi Madvar & Mohammad Ali Taher. (2024) Preparation of fluorescent sensor based on Zn metal-organic framework for detection and determination of raloxifene as an anticancer drug. Environmental Research 240, pages 117449.
Crossref
Karen M Tuesley, Penelope M Webb, Melinda M Protani, Katrina Spilsbury, Sallie-Anne Pearson, Michael D Coory, Peter Donovan, Christopher Steer, Louise M Stewart, Nirmala Pandeya & Susan J Jordan. (2022) Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older. JNCI: Journal of the National Cancer Institute 114:6, pages 878-884.
Crossref
Shu-ting Lin, Yi-zhong Li, Xiao-qi Sun, Qian-qian Chen, Shun-fa Huang, Shu Lin & Si-qing Cai. (2021) Update on the Role of Neuropeptide Y and Other Related Factors in Breast Cancer and Osteoporosis. Frontiers in Endocrinology 12.
Crossref
Masoumeh Ghalkhani, Saeed Shahrokhian & Mostafa Navabi. (2021) Development of an electrochemical sensor based on (rGO-CNT) nanocomposite for raloxifene analysis. Materials Chemistry and Physics 263, pages 124131.
Crossref
Xiao-Yu Qi, Hao Liu, Dong-Dong Bi, Xiang-Tao Wang, Yi-Fei Guo, Ting Hao, Bao-Xin Zhang, Xing-Guo Wang & Mei-Hua Han. (2019) Combined administration on You-Gui Yin and low-dose Raloxifene partially attenuates the bone loss in ovariectomized mice through the proliferation and osteogenic differentiation of bone marrow stromal cells. Phytomedicine 53, pages 286-293.
Crossref
Imaneh KhorsandReyhaneh KashefMasumeh GhazanfarpourElaheh MansouriSareh DashtiTalat Khadivzadeh. (2018) The Beneficial and Adverse Effects of Raloxifene in Menopausal Women: A Mini Review. Journal of Menopausal Medicine 24:3, pages 183.
Crossref
Meihua Han, Xiaoyu Qi, Dongdong Bi, Yijing Li, Yifei Guo, Xiangtao Wang & Li Feng. (2018) Administration of raloxifene hydrochloride nanosuspensions partially attenuates bone loss in ovariectomized mice. RSC Advances 8:42, pages 23748-23756.
Crossref
Abul Kalam, Sushama Talegaonkar & Divya Vohora. (2017) Effects of raloxifene against letrozole-induced bone loss in chemically-induced model of menopause in mice. Molecular and Cellular Endocrinology 440, pages 34-43.
Crossref
Saeed Shahrokhian, Masoumeh Ghalkhani, Hamed Balotf & Razieh Salimian. (2016) Application of glassy carbon electrode modified with a carbon nanoparticle/melamine thin film for voltammetric determination of raloxifene. Journal of Electroanalytical Chemistry 780, pages 126-133.
Crossref
Sang Jun Han, Khurshida Begum, Charles E. Foulds, Ross A. Hamilton, Suzanna Bailey, Anna Malovannaya, Doug Chan, Jun Qin & Bert W. O’Malley. (2016) The Dual Estrogen Receptor α Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety . Molecular Pharmacology 89:1, pages 14-26.
Crossref
Xiaotong Zhou, Shaoxiang Wang, Hua Sun & Baojian Wu. (2015) Sulfonation of raloxifene in HEK293 cells overexpressing SULT1A3: Involvement of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in excretion of sulfate metabolites. Drug Metabolism and Pharmacokinetics 30:6, pages 425-433.
Crossref
Samy A.F. Morad & Myles C. Cabot. (2015) Tamoxifen regulation of sphingolipid metabolism—Therapeutic implications. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1851:9, pages 1134-1145.
Crossref
Elena Huerta-Ramos, Susana Ochoa, Mercedes Roca, Eva Miquel & Judith Usall. (2015) The effect of raloxifene on symptoms and cognitive functioning in a postmenopausal schizophrenia patient: a case report. Archives of Women's Mental Health 18:2, pages 259-261.
Crossref
Juliana Q. Reimão, Danilo C. Miguel, Noemi N. Taniwaki, Cristiana T. Trinconi, Jenicer K. U. Yokoyama-Yasunaka & Silvia R. B. Uliana. (2014) Antileishmanial Activity of the Estrogen Receptor Modulator Raloxifene. PLoS Neglected Tropical Diseases 8:5, pages e2842.
Crossref
Mi Hye Kim, You Yeon Choi, Jae Min Han, Hyoun-su Lee, Seong Bin Hong, Seok-geun Lee & Woong Mo Yang. (2014) Ameliorative effects of Schizandra chinensis on osteoporosis via activation of estrogen receptor (ER)-α/-β. Food Funct. 5:7, pages 1594-1601.
Crossref
Ming Fang, Xin-Chi Wu & Wenlong Huang. (2013) Raloxifene Upregulated Mesangial Cell MMP-2 Activity via ER-β Through Transcriptional Regulation. Cell Biochemistry and Biophysics 67:2, pages 607-613.
Crossref
Z.D. Yang, J. Yu & Q. Zhang. (2013) Effects of raloxifene on cognition, mental health, sleep and sexual function in menopausal women: A systematic review of randomized controlled trials. Maturitas 75:4, pages 341-348.
Crossref
Hongyun Lu, Hong Liu, Fang Hu, Lingling Zou, Shunkui Luo & Liao Sun. (2013) Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis. International Journal of Endocrinology 2013, pages 1-7.
Crossref
A. Cleve, K.-H. Fritzemeier, B. Haendler, N. Heinrich, C. Möller, W. Schwede & T. Wintermantel. 2012. Sex and Gender Differences in Pharmacology. Sex and Gender Differences in Pharmacology 543 587 .
. (2012) Current World Literature. Current Opinion in Obstetrics & Gynecology 24:1, pages 49-55.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.